Low Molecular Weight Heparins as Extended Prophylaxis Against Recurrent Thrombosis in Cancer Patients

Author： Engman Cocav A.   Zacharski Leo R.  

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.6, Iss.7, 2008-08, pp. : 637-645

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low molecular weight heparins

By Aguilar O.M.   Kleiman N.S.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 6, 2000-09 ,pp. : 1091-1103

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of a Low-Molecular-Weight Heparin in Prolonged Prophylaxis Against Deep Vein Thrombosis After Total Hip Replacement

By Detournay B.  

PharmacoEconomics, Vol. 13, Iss. 1 Part 2, 1998-01 ,pp. : 81-89

Adis International

Access to resources Recommend Favorite

The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke

By Kiphuth Ines C   Köhrmann Martin   Huttner Hagen B   Schellinger Peter D  

Expert Opinion on Drug Safety, Vol. 8, Iss. 5, 2009-09 ,pp. : 585-597

Informa Healthcare

Access to resources Recommend Favorite

Heparin/low molecular weight heparins: Fatal heparin-induced thrombocytopenia and thrombosis syndrome in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1231, 2008-01 ,pp. : 16-17

Adis International

Access to resources Recommend Favorite

Pulmonary Delivery of Low Molecular Weight Heparins

By Yang Tianzhi   Mustafa Fatima   Bai Shuhua   Ahsan Fakhrul  

Pharmaceutical Research, Vol. 21, Iss. 11, 2004-11 ,pp. : 2009-2016

Springer Publishing Company

Access to resources Recommend Favorite